HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

rotenoisin B

has anti-carcinogenic activity in hepatic cancer cells; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Badaboina, Srilatha: 1 article (07/2015)
2.	Bai, Hyoung-Woo: 1 article (07/2015)
3.	Chung, Byung Yeoup: 1 article (07/2015)
4.	Kim, Tae Hoon: 1 article (07/2015)
5.	Lee, Tae-Hoon: 1 article (07/2015)
6.	Na, Yun Hee: 1 article (07/2015)
7.	Park, Chul-Hong: 1 article (07/2015)

Related Diseases

1.

Liver Neoplasms (Liver Cancer)

07/24/2015 - "Our results showed rotenoisin B inhibited hepatic cancer cells' proliferation in a dose dependent manner and increased in apoptotic cells. "
07/24/2015 - "These results suggest that rotenoisin B might be a potent anticancer candidate similar to rotenone in hepatic cancer cells with low toxicity to normal cells even at high concentrations compared to rotenone. "
07/24/2015 - "The present work was designed to investigate the anticancer activity of rotenoisin B with low toxicity and its molecular mechanism in hepatic cancer cells compared to a parent compound, rotenone. "
07/24/2015 - "Novel Radiolytic Rotenone Derivative, Rotenoisin B with Potent Anti-Carcinogenic Activity in Hepatic Cancer Cells."

Related Drugs and Biologics

1.	Rotenone